OrbiMed Capital GP V LLC, Director at Adaptimmune Therapeutics PLC (ADAP), sold 18,700 shares at $13.49 ($254K) on 2018-06-06, disclosed to the SEC on 2018-06-06.
Open-market sale of $254k ADAP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.57 | 17,100 | $232K | 91.5% |
| 2 | $13.49 | 1,600 | $22K | 8.5% |
| Total | $13.56 avg | 18,700 | $254K | 100% |
| Filing → |
| CMPX | BUY | 2022-05-10 | $339K | — | Filing → |
| CRVS | SELL | 2021-09-22 | $13.5M | — | Filing → |
| ARPO | SELL | 2020-12-10 | $42K | — | Filing → |